Why Current PTH Assays Mislead Clinical Decision Making in Patients with Secondary Hyperparathyroidism

Publisher： Karger

E-ISSN： 2235-3186|136|2|137-142

ISSN： 1660-8151

Source： Nephron, Vol.136, Iss.2, 2017-02, pp. : 137-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Secondary Hyperparathyroidism in Chronic Dialysis Patients

By  

Blood Purification, Vol. 34, Iss. 3-4, 2012-10 ,pp. : 211-212

Karger

Access to resources Recommend Favorite

Clinical Effect of Intravenous Calcitriol Administration on Secondary Hyperparathyroidism

By  

Nephron, Vol. 90, Iss. 4, 2002-04 ,pp. : 413-423

Karger

Access to resources Recommend Favorite

Effects of Treatment of Secondary Hyperparathyroidism on the Lipid Profile in Patients on Hemodialysis

By  

Blood Purification, Vol. 16, Iss. 1, 1998-02 ,pp. : 22-29

Karger

Access to resources Recommend Favorite

Secondary Hyperparathyroidism, Proinflammatory Cytokines and Response to Epoietin in Anemic Maintenance Dialysis Patients

By  

Nephron, Vol. 88, Iss. 4, 2001-07 ,pp. : 391-392

Karger

Access to resources Recommend Favorite

Parathyroidectomy Reduces Intradialytic Hypotension in Hemodialysis Patients with Secondary Hyperparathyroidism

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 4-5, 2013-09 ,pp. : 323-331

Karger

Access to resources Recommend Favorite